Release Date: 31/10/19 18:02 Summary: Letter to shareholders re ASX delisting Price Sensitive: No Download Document 259.4KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%